nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—ESR1—Alzheimer's disease	0.713	1	CbGaD
Fluoxymesterone—Polycythaemia—Memantine—Alzheimer's disease	0.0131	0.152	CcSEcCtD
Fluoxymesterone—Hirsutism—Donepezil—Alzheimer's disease	0.00543	0.063	CcSEcCtD
Fluoxymesterone—Coagulopathy—Galantamine—Alzheimer's disease	0.00523	0.0607	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Rivastigmine—Alzheimer's disease	0.00411	0.0477	CcSEcCtD
Fluoxymesterone—PRLR—brain—Alzheimer's disease	0.00372	0.144	CbGeAlD
Fluoxymesterone—Coagulopathy—Memantine—Alzheimer's disease	0.00368	0.0427	CcSEcCtD
Fluoxymesterone—Coagulopathy—Rivastigmine—Alzheimer's disease	0.0036	0.0418	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00293	0.034	CcSEcCtD
Fluoxymesterone—ESR1—blood vessel—Alzheimer's disease	0.00259	0.1	CbGeAlD
Fluoxymesterone—Libido decreased—Donepezil—Alzheimer's disease	0.00247	0.0287	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.00227	0.0264	CcSEcCtD
Fluoxymesterone—Libido decreased—Memantine—Alzheimer's disease	0.00224	0.026	CcSEcCtD
Fluoxymesterone—Libido decreased—Rivastigmine—Alzheimer's disease	0.00219	0.0255	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00206	0.0239	CcSEcCtD
Fluoxymesterone—Haemoglobin—Galantamine—Alzheimer's disease	0.00205	0.0238	CcSEcCtD
Fluoxymesterone—Haemorrhage—Galantamine—Alzheimer's disease	0.00204	0.0237	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00202	0.0234	CcSEcCtD
Fluoxymesterone—Haemoglobin—Donepezil—Alzheimer's disease	0.00159	0.0185	CcSEcCtD
Fluoxymesterone—Haemorrhage—Donepezil—Alzheimer's disease	0.00158	0.0184	CcSEcCtD
Fluoxymesterone—ESR1—embryo—Alzheimer's disease	0.00154	0.0598	CbGeAlD
Fluoxymesterone—Anxiety—Galantamine—Alzheimer's disease	0.00151	0.0175	CcSEcCtD
Fluoxymesterone—Haemoglobin—Memantine—Alzheimer's disease	0.00145	0.0168	CcSEcCtD
Fluoxymesterone—Haemorrhage—Memantine—Alzheimer's disease	0.00144	0.0167	CcSEcCtD
Fluoxymesterone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00141	0.0164	CcSEcCtD
Fluoxymesterone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00141	0.0163	CcSEcCtD
Fluoxymesterone—Alopecia—Donepezil—Alzheimer's disease	0.0014	0.0162	CcSEcCtD
Fluoxymesterone—AR—forebrain—Alzheimer's disease	0.00139	0.0539	CbGeAlD
Fluoxymesterone—ESR1—forebrain—Alzheimer's disease	0.00137	0.0529	CbGeAlD
Fluoxymesterone—Paraesthesia—Galantamine—Alzheimer's disease	0.0013	0.0151	CcSEcCtD
Fluoxymesterone—AR—telencephalon—Alzheimer's disease	0.00128	0.0496	CbGeAlD
Fluoxymesterone—Alopecia—Memantine—Alzheimer's disease	0.00127	0.0148	CcSEcCtD
Fluoxymesterone—ESR1—telencephalon—Alzheimer's disease	0.00126	0.0486	CbGeAlD
Fluoxymesterone—Alopecia—Rivastigmine—Alzheimer's disease	0.00124	0.0144	CcSEcCtD
Fluoxymesterone—Anxiety—Donepezil—Alzheimer's disease	0.00117	0.0136	CcSEcCtD
Fluoxymesterone—NR3C1—embryo—Alzheimer's disease	0.00114	0.0441	CbGeAlD
Fluoxymesterone—Danazol—CCL2—Alzheimer's disease	0.0011	0.301	CrCbGaD
Fluoxymesterone—Hypersensitivity—Galantamine—Alzheimer's disease	0.00107	0.0124	CcSEcCtD
Fluoxymesterone—Anxiety—Memantine—Alzheimer's disease	0.00106	0.0123	CcSEcCtD
Fluoxymesterone—Anxiety—Rivastigmine—Alzheimer's disease	0.00104	0.0121	CcSEcCtD
Fluoxymesterone—SHBG—central nervous system—Alzheimer's disease	0.00101	0.0392	CbGeAlD
Fluoxymesterone—Paraesthesia—Donepezil—Alzheimer's disease	0.00101	0.0117	CcSEcCtD
Fluoxymesterone—NR3C1—forebrain—Alzheimer's disease	0.00101	0.039	CbGeAlD
Fluoxymesterone—SHBG—cerebellum—Alzheimer's disease	0.00099	0.0384	CbGeAlD
Fluoxymesterone—NR3C1—telencephalon—Alzheimer's disease	0.000926	0.0359	CbGeAlD
Fluoxymesterone—Paraesthesia—Memantine—Alzheimer's disease	0.000917	0.0107	CcSEcCtD
Fluoxymesterone—Headache—Galantamine—Alzheimer's disease	0.000909	0.0106	CcSEcCtD
Fluoxymesterone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000897	0.0104	CcSEcCtD
Fluoxymesterone—Nausea—Galantamine—Alzheimer's disease	0.000862	0.01	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000829	0.00962	CcSEcCtD
Fluoxymesterone—SHBG—brain—Alzheimer's disease	0.000804	0.0312	CbGeAlD
Fluoxymesterone—AR—nervous system—Alzheimer's disease	0.000755	0.0293	CbGeAlD
Fluoxymesterone—Hypersensitivity—Memantine—Alzheimer's disease	0.000753	0.00874	CcSEcCtD
Fluoxymesterone—ESR1—nervous system—Alzheimer's disease	0.000741	0.0287	CbGeAlD
Fluoxymesterone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000736	0.00855	CcSEcCtD
Fluoxymesterone—AR—central nervous system—Alzheimer's disease	0.000727	0.0282	CbGeAlD
Fluoxymesterone—ESR1—central nervous system—Alzheimer's disease	0.000714	0.0277	CbGeAlD
Fluoxymesterone—Headache—Donepezil—Alzheimer's disease	0.000705	0.00818	CcSEcCtD
Fluoxymesterone—ESR1—cerebellum—Alzheimer's disease	0.000698	0.027	CbGeAlD
Fluoxymesterone—Nausea—Donepezil—Alzheimer's disease	0.000668	0.00776	CcSEcCtD
Fluoxymesterone—Headache—Memantine—Alzheimer's disease	0.00064	0.00743	CcSEcCtD
Fluoxymesterone—Headache—Rivastigmine—Alzheimer's disease	0.000626	0.00727	CcSEcCtD
Fluoxymesterone—Nausea—Memantine—Alzheimer's disease	0.000607	0.00705	CcSEcCtD
Fluoxymesterone—Nausea—Rivastigmine—Alzheimer's disease	0.000594	0.00689	CcSEcCtD
Fluoxymesterone—AR—brain—Alzheimer's disease	0.000577	0.0224	CbGeAlD
Fluoxymesterone—ESR1—brain—Alzheimer's disease	0.000567	0.022	CbGeAlD
Fluoxymesterone—NR3C1—nervous system—Alzheimer's disease	0.000547	0.0212	CbGeAlD
Fluoxymesterone—NR3C1—central nervous system—Alzheimer's disease	0.000527	0.0204	CbGeAlD
Fluoxymesterone—NR3C1—cerebellum—Alzheimer's disease	0.000515	0.0199	CbGeAlD
Fluoxymesterone—Triamcinolone—BCHE—Alzheimer's disease	0.000457	0.125	CrCbGaD
Fluoxymesterone—Danazol—ESR1—Alzheimer's disease	0.000423	0.116	CrCbGaD
Fluoxymesterone—NR3C1—brain—Alzheimer's disease	0.000418	0.0162	CbGeAlD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—Alzheimer's disease	0.00038	0.104	CrCbGaD
Fluoxymesterone—Dexamethasone—NOS2—Alzheimer's disease	0.000349	0.0954	CrCbGaD
Fluoxymesterone—Progesterone—ESR1—Alzheimer's disease	0.000219	0.0599	CrCbGaD
Fluoxymesterone—Triamcinolone—PTGS2—Alzheimer's disease	0.00021	0.0575	CrCbGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000173	0.00101	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—Alzheimer's disease	0.000172	0.0471	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000172	0.001	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	0.000171	0.000998	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.00017	0.000994	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	0.00017	0.000993	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	0.000169	0.000985	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000169	0.000984	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000168	0.000978	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000167	0.000972	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—S100B—Alzheimer's disease	0.000165	0.00096	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NPY—Alzheimer's disease	0.000164	0.000958	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IAPP—Alzheimer's disease	0.000163	0.000952	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000163	0.00095	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—LPL—Alzheimer's disease	0.000162	0.000946	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—Alzheimer's disease	0.000161	0.000938	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	0.000161	0.000937	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—NOS3—Alzheimer's disease	0.000161	0.000936	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL1A—Alzheimer's disease	0.000159	0.000927	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PHF1—Alzheimer's disease	0.000159	0.000926	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CRH—Alzheimer's disease	0.000158	0.000924	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000156	0.00091	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000154	0.000898	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MEF2C—Alzheimer's disease	0.000154	0.000896	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AGER—Alzheimer's disease	0.000152	0.000888	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MAPK8—Alzheimer's disease	0.000152	0.000885	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.000152	0.000885	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PRKCG—Alzheimer's disease	0.000151	0.000879	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NPS—Alzheimer's disease	0.00015	0.000876	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00015	0.000872	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000149	0.000872	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	0.000149	0.000866	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTK2B—Alzheimer's disease	0.000147	0.000859	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	0.000147	0.000855	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000145	0.000846	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000144	0.000838	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NTRK2—Alzheimer's disease	0.000143	0.000836	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GAB2—Alzheimer's disease	0.000143	0.000836	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SST—Alzheimer's disease	0.000143	0.000836	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GSK3A—Alzheimer's disease	0.000142	0.000829	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APP—Alzheimer's disease	0.00014	0.000815	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000139	0.00081	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—IL1B—Alzheimer's disease	0.000137	0.000797	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.000137	0.000796	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—Alzheimer's disease	0.000136	0.000796	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—LEP—Alzheimer's disease	0.000136	0.000793	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000133	0.000776	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000133	0.000774	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PLCB1—Alzheimer's disease	0.000132	0.000769	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP2D6—Alzheimer's disease	0.000131	0.0356	CrCbGaD
Fluoxymesterone—PRLR—Immune System—CALM1—Alzheimer's disease	0.00013	0.000761	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000129	0.000753	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000126	0.000737	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000126	0.000733	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK8—Alzheimer's disease	0.000125	0.000731	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NGFR—Alzheimer's disease	0.000123	0.000717	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PHF1—Alzheimer's disease	0.000122	0.000713	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PHF1—Alzheimer's disease	0.00012	0.000702	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.00012	0.000701	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADAM10—Alzheimer's disease	0.00012	0.000701	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—Alzheimer's disease	0.00012	0.000698	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP2D6—Alzheimer's disease	0.000119	0.0326	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	0.000118	0.000691	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	0.000117	0.000681	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—INS—Alzheimer's disease	0.000116	0.000677	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	0.000115	0.00067	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TGFB1—Alzheimer's disease	0.000115	0.00067	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.000115	0.000669	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—S100B—Alzheimer's disease	0.000114	0.000662	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000113	0.00066	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	0.000113	0.00066	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—Alzheimer's disease	0.000113	0.000659	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—GSK3B—Alzheimer's disease	0.000113	0.000656	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	0.000112	0.000655	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.000112	0.000654	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CREB1—Alzheimer's disease	0.000112	0.000651	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000111	0.00065	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.00011	0.000644	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.000109	0.000635	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF2—Alzheimer's disease	0.000108	0.000631	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—GSK3B—Alzheimer's disease	0.000105	0.000615	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.000105	0.000613	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CREB1—Alzheimer's disease	0.000105	0.00061	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1R—Alzheimer's disease	0.000105	0.00061	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—TFAM—Alzheimer's disease	0.000102	0.000597	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.000101	0.00059	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000101	0.000589	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—Alzheimer's disease	0.0001	0.0274	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—LPL—Alzheimer's disease	0.0001	0.000585	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MEF2C—Alzheimer's disease	9.93e-05	0.000579	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	9.87e-05	0.000576	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	9.85e-05	0.000574	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PRKCG—Alzheimer's disease	9.75e-05	0.000568	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—Alzheimer's disease	9.69e-05	0.000565	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	9.5e-05	0.000554	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NGF—Alzheimer's disease	9.49e-05	0.000554	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—BCL2—Alzheimer's disease	9.37e-05	0.000547	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—Alzheimer's disease	9.24e-05	0.000539	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCR5—Alzheimer's disease	9.24e-05	0.000539	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	9.1e-05	0.000531	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR2A—Alzheimer's disease	9.04e-05	0.000527	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	9.02e-05	0.000526	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	9.01e-05	0.000525	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	8.83e-05	0.000515	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	8.72e-05	0.000508	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	8.58e-05	0.0005	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—Alzheimer's disease	8.45e-05	0.000493	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CALM1—Alzheimer's disease	8.43e-05	0.000492	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LEP—Alzheimer's disease	8.4e-05	0.00049	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOE—Alzheimer's disease	8.4e-05	0.00049	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	8.38e-05	0.000489	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	8.38e-05	0.000489	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	8.36e-05	0.000487	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	8.36e-05	0.000487	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	8.33e-05	0.000486	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CAV1—Alzheimer's disease	8.32e-05	0.000486	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL1B—Alzheimer's disease	8.28e-05	0.000483	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ESR1—Alzheimer's disease	8.02e-05	0.000468	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	8.01e-05	0.000467	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—Alzheimer's disease	7.98e-05	0.000466	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—F2—Alzheimer's disease	7.92e-05	0.000462	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—TFAM—Alzheimer's disease	7.88e-05	0.00046	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	7.79e-05	0.000454	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—TFAM—Alzheimer's disease	7.76e-05	0.000453	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH1—Alzheimer's disease	7.75e-05	0.000452	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	7.7e-05	0.000449	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK8—Alzheimer's disease	7.6e-05	0.000443	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	7.49e-05	0.000437	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	7.47e-05	0.000436	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—Alzheimer's disease	7.38e-05	0.00043	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	7.34e-05	0.000428	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	7.32e-05	0.000427	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GSK3B—Alzheimer's disease	7.28e-05	0.000424	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CREB1—Alzheimer's disease	7.22e-05	0.000421	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—INS—Alzheimer's disease	7.18e-05	0.000419	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	7.16e-05	0.000418	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	7.11e-05	0.000415	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL2—Alzheimer's disease	7.06e-05	0.000412	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	6.95e-05	0.000405	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1—Alzheimer's disease	6.94e-05	0.000405	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	6.94e-05	0.000405	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	6.83e-05	0.000399	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	6.77e-05	0.000395	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	6.73e-05	0.000393	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	6.61e-05	0.000385	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	6.52e-05	0.000381	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	6.48e-05	0.000378	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TTR—Alzheimer's disease	6.48e-05	0.000378	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	6.45e-05	0.000376	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	6.34e-05	0.00037	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOS3—Alzheimer's disease	6.29e-05	0.000367	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—Alzheimer's disease	6.29e-05	0.000367	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	6.25e-05	0.000364	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EIF2S1—Alzheimer's disease	6.16e-05	0.000359	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	6.09e-05	0.000355	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	6.04e-05	0.000352	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	5.93e-05	0.000346	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	5.78e-05	0.000337	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	5.7e-05	0.000332	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PYY—Alzheimer's disease	5.66e-05	0.00033	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	5.48e-05	0.000319	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	5.47e-05	0.000319	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	5.43e-05	0.000317	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	5.37e-05	0.000313	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—Alzheimer's disease	5.34e-05	0.000312	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—Alzheimer's disease	5.07e-05	0.000296	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	5.03e-05	0.000293	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	4.99e-05	0.000291	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK8—Alzheimer's disease	4.91e-05	0.000286	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDK5—Alzheimer's disease	4.91e-05	0.000286	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—Alzheimer's disease	4.85e-05	0.000283	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EIF2S1—Alzheimer's disease	4.74e-05	0.000277	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	4.74e-05	0.000276	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR6—Alzheimer's disease	4.73e-05	0.000276	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	4.69e-05	0.000274	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	4.67e-05	0.000272	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	4.65e-05	0.000271	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	4.58e-05	0.000267	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—Alzheimer's disease	4.55e-05	0.000265	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.54e-05	0.000265	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—Alzheimer's disease	4.53e-05	0.000265	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—Alzheimer's disease	4.48e-05	0.000261	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—Alzheimer's disease	4.39e-05	0.000256	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	4.39e-05	0.000256	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	4.32e-05	0.000252	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSENEN—Alzheimer's disease	4.29e-05	0.00025	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APH1A—Alzheimer's disease	4.23e-05	0.000247	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	4.22e-05	0.000246	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—Alzheimer's disease	4.19e-05	0.000245	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—Alzheimer's disease	4.16e-05	0.000243	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	4.14e-05	0.000241	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NCSTN—Alzheimer's disease	4.12e-05	0.00024	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LRP1—Alzheimer's disease	4.02e-05	0.000234	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GFAP—Alzheimer's disease	3.93e-05	0.000229	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GAL—Alzheimer's disease	3.93e-05	0.000229	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.49e-05	0.000204	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—A2M—Alzheimer's disease	3.46e-05	0.000202	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—Alzheimer's disease	3.43e-05	0.0002	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSEN2—Alzheimer's disease	3.35e-05	0.000195	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—Alzheimer's disease	3.14e-05	0.000183	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NPY—Alzheimer's disease	3.08e-05	0.00018	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IAPP—Alzheimer's disease	3.07e-05	0.000179	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—Alzheimer's disease	3.01e-05	0.000175	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CRH—Alzheimer's disease	2.98e-05	0.000174	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH1—Alzheimer's disease	2.91e-05	0.00017	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—Alzheimer's disease	2.89e-05	0.000169	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NPS—Alzheimer's disease	2.82e-05	0.000165	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPP3CA—Alzheimer's disease	2.81e-05	0.000164	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTK2B—Alzheimer's disease	2.77e-05	0.000161	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—Alzheimer's disease	2.74e-05	0.00016	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NTRK2—Alzheimer's disease	2.69e-05	0.000157	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GAB2—Alzheimer's disease	2.69e-05	0.000157	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SST—Alzheimer's disease	2.69e-05	0.000157	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GSK3A—Alzheimer's disease	2.67e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APP—Alzheimer's disease	2.62e-05	0.000153	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLCB1—Alzheimer's disease	2.47e-05	0.000144	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NGFR—Alzheimer's disease	2.31e-05	0.000135	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—Alzheimer's disease	2.28e-05	0.000133	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADAM10—Alzheimer's disease	2.26e-05	0.000132	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH1—Alzheimer's disease	2.24e-05	0.000131	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	2.21e-05	0.000129	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—S100B—Alzheimer's disease	2.13e-05	0.000124	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—Alzheimer's disease	2.11e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—Alzheimer's disease	2.08e-05	0.000121	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF2—Alzheimer's disease	2.03e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1R—Alzheimer's disease	1.96e-05	0.000115	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LPL—Alzheimer's disease	1.88e-05	0.00011	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MEF2C—Alzheimer's disease	1.87e-05	0.000109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCG—Alzheimer's disease	1.83e-05	0.000107	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NGF—Alzheimer's disease	1.78e-05	0.000104	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR5—Alzheimer's disease	1.73e-05	0.000101	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2A—Alzheimer's disease	1.7e-05	9.9e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CALM1—Alzheimer's disease	1.58e-05	9.23e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—Alzheimer's disease	1.58e-05	9.2e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—Alzheimer's disease	1.58e-05	9.2e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CAV1—Alzheimer's disease	1.56e-05	9.12e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—F2—Alzheimer's disease	1.49e-05	8.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.46e-05	8.49e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GSK3B—Alzheimer's disease	1.37e-05	7.97e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CREB1—Alzheimer's disease	1.36e-05	7.9e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INS—Alzheimer's disease	1.35e-05	7.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL2—Alzheimer's disease	1.33e-05	7.73e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—Alzheimer's disease	1.3e-05	7.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOS3—Alzheimer's disease	1.18e-05	6.89e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—Alzheimer's disease	1.08e-05	6.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—Alzheimer's disease	1e-05	5.85e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK8—Alzheimer's disease	9.22e-06	5.38e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—Alzheimer's disease	8.52e-06	4.97e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—Alzheimer's disease	8.36e-06	4.87e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—Alzheimer's disease	8.23e-06	4.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—Alzheimer's disease	7.82e-06	4.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—Alzheimer's disease	6.43e-06	3.75e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—Alzheimer's disease	5.89e-06	3.44e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—Alzheimer's disease	5.43e-06	3.17e-05	CbGpPWpGaD
